With 1,73,195 cases, Maharashtra has the highest number of active cases.
Her research was focused on urban development, macro-economic reforms, industrial development, and social sector development issues in India.
There are 2,89,240 active cases of coronavirus infections in the country which comprises 2.86 per cent of the total caseload.
COVID-19 cases in the country jumped from 10 lakh to 20 lakh in 21 days, while it had taken 59 days for the cases to cross the 10 lakh-mark.
The number of people who have recuperated from the disease surged to 96,36,487 pushing the national recovery rate to 95.65 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent.
The number of active coronavirus cases in the country has surpassed the 16-lakh mark, the ministry's data updated at 8 am showed.
The number of people who have recuperated from the disease surged to 96,06,111, pushing the national recovery rate to 95.53 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent, according to the data.
Active cases of infection fell below 9 lakh after a month comprising 12.94 per cent of the total caseload
The bulk of this money will, however, be spent on buying imported equipment, mainly from Europe and China.
The joint secretary also said a high-level task force to work on frontiers of science related to vaccines and drug testing was formed on Sunday.
The Central Institute for Cotton Research (CICR), the cotton research institute of the Indian Council of Agricultural Research, has contested Monsanto's claim that the pink bollworm, a pest that feeds on cotton, has developed resistance to its Bollgard cotton.
The number of new coronavirus cases in India hit a record daily high since the outbreak of the pandemic with over 1.15 lakh new infections being reported in a span of 24 hours, pushing the nationwide COVID-19 tally to 1,28,01,785, according to the Union health ministry data updated on Wednesday.
'At the heart of the strategic relationship between our countries are economic ties.'
'The ICMR and Biological E Limited, Hyderabad, have developed highly purified antisera (raised in animals) for prophylaxis and treatment of COVID-19,' the apex health research body said on Thursday. The 'antisera' is yet to undergo human clinical trials to establish its safety and efficacy and Drugs Controller General of India would be approached soon in this regard, Dr Samiran Panda, the head of epidemiology and communicable diseases at the ICMR said.
India logged 44,877 infections, while the death toll climbed to 5,08,665 with 684 fresh fatalities, the data updated at 8 am stated.
Over 21 per cent of the population, aged 10 years and above, showed evidence of past exposure to COVID-19 in the Indian Council of Medical Research's latest national serosurvey, the government said on Thursday, noting that a large proportion of people are still vulnerable to the infection.
This was the ninth day in a row that the COVID-19 tally increased by more than 50,000.
Registering a steady increase for the 18th day in row, the active cases have increased to 4,86,310 comprising 4.06 per cent of the total infections, while the recovery rate has further dropped to 94.58 per cent, the data stated.
Safety and Efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication.
The recession in the advanced countries could continue for a while yet.
The officials of Indian Council of Medical Research (ICMR) also said there are now 1,065 testing labs in the country -- 768 in the public sector and 297 in private.
The government also appointed Dr Vinod Paul, a pediatrician at the AIIMS, as a member of the NITI Aayog
The active cases comprise 3.42 per cent of the total infections.
Thirty districts in the country, including 13 in Kerala, eight in Mizoram, four in Meghalaya, three each in Manipur and Arunachal Pradesh, two in Sikkim and one in Meghalaya are reporting a weekly positivity rate of over 10 per cent.
'Those who had no participation in the freedom struggle and creating history are keeping out one of the heroes of the independence struggle. This act, done out of political vindictiveness, is not good and shows their narrow mindset. It is an insult of each and every freedom fighter,' Raut claimed.
Climate and sustainable development financing, multilateral institution reforms, regulation of digital assets, the spillover effect on developing economies from actions of western central banks, energy and food security in the backdrop of war in Europe, and sanctions on Russia and their impact on the global economy are some of the agenda items that India will take up as President of G-20, Finance Minister Nirmala Sitharaman said on Tuesday. India will take over as President of the powerful international grouping on December 1 for a year. There will be around 200 meetings throughout the country, with the summit Heads of State meeting expected to be held in New Delhi next September.
When several opposition MPs expressed their desire to ask questions about the Centre's vaccination policy such as increasing the gap between two doses, the BJP MPs strongly opposed it and few of them even demanded postponement of the meeting and walked out, the sources said.
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
The second wave is expected based on what is happening in Europe, the govt said.
The Union health ministry on Wednesday dismissed media reports claiming there was dissent from technical experts about increasing the gap between two Covishield doses and said the decision was based on scientific reason about the behaviour of adenovector vaccines.
The death toll due to the disease has climbed to 5,16,281 with 149 daily fatalities being recorded, data updated by the ministry at 8 am showed.
Bharat Biotech's Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.
In the trial, the vaccine will be given by the intramuscular route in two doses on day 0 and day 28.
'SII has started stockpiling the vaccine and now has roughly 40 million doses ready. It is using some of the capacities it had for under development products for the COVID-19 vaccine and by January we will have a capacity to make 100 million doses per month and a stockpile of 200 million doses.'
A total of 76,56,478 people have recuperated from the infection so far, pushing the national recovery rate to 92.09 per cent, while the case fatality rate stands at 1.49 per cent.
The total COVID-19 tally includes 9,287 cases of the Omicron variant.
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16, 60 lakh on September 28, 70 lakh on October 11 and crossed 80 lakh on October 29.
India and Indians can ignore Pakistan, but that cannot be said of other nations in the neighbourhood, where New Delhi's 'Neighbourhood First' policy constantly reverberates. Four of the eight SAARC member-nations are Muslim -- Afghanistan and Pakistan, Bangladesh and the Maldives. The rulers decide the nation's India or anti-India policy in the first two, and street-opinion contributes to the same in the latter two, points out N Sathiya Moorthy.
A total of 74,91,513 people have recuperated from COVID-19 so far taking the national recovery rate to 91.54 per cent while the case fatality rate was recorded at 1.49 per cent.
An increase of 80,287 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances